Teva Acquisition of Taiyo Prompts Concerns Among Japanese Generic Firms
This article was originally published in PharmAsia News
Executive Summary
Japan's Taiyo Pharmaceutical Industry has agreed to sell a majority stake to the world's largest generic manufacturer Teva Pharmaceutical Industries, raising many questions about the future of the generics sector in Japan